China, Israel investing big in the medical imaging AI market

Reenita Das, a partner and senior vice president of healthcare and life sciences at Frost & Sullivan, wrote a new column examining the efforts being made by China and Israel to become leaders in the medical imaging artificial intelligence (AI) market. 

Calling medical imaging analysis “the bellwether application area for healthcare AI,” Das went on to highlight key investments made in both countries in the column, published online by Forbes.

“Israel is another country which, despite its size, is doing well in the AI medical image analysis field,” she wrote. “Like the U.S., Israel has probably benefited from the transfer of military advances in computer vision to medical applications.”

Click below to read the full article from Forbes.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.